InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Halstead Michael, Vice-Président Exécutif. Director active across 2 companies, notably Intra-Cellular Therapies, Inc.. Aggregated, 20 disclosures have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €2m. History available since 21 December 2021. The latest transaction was filed on 21 September 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Halstead Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
100,000 股@ US$13.4705Common SharesSEC:0000912282-26-001293:0
标准退出：2026年12月20日 (T+90)
21,307 股@ US$132.0043.1% 占其流量Common StockSEC:0000950170-25-049646:0
13,133 股Common StockSEC:0000950170-25-036591:0
12,239 股Common StockSEC:0000950170-25-032586:0
11,017 股0Common StockSEC:0000950170-25-013763:0
22,869 股@ US$23.948.6% 占其流量Common StockSEC:0000950170-24-127275:0
12,912 股@ US$66.1413.1% 占其流量Common StockSEC:0000950170-24-029581:0
13,132 股Common StockSEC:0000950170-24-028820:0
7,907 股Common StockSEC:0000950170-24-021575:0
11,860 股0Common StockSEC:0000950170-24-011400:0
46,115 股@ US$12.738.9% 占其流量Common StockSEC:0000950170-24-004320:0
15,164 股@ US$15.473.7% 占其流量Common StockSEC:0001209191-23-055207:0
16,708 股0Common StockSEC:0001209191-23-018285:0
7,906 股Common StockSEC:0001209191-23-013437:0
11,139 股Common StockSEC:0001209191-23-011997:0
50,000 股@ US$15.4712.4% 占其流量Common StockSEC:0001209191-22-059507:0
7,906 股Common StockSEC:0001209191-22-013356:0
11,139 股Common StockSEC:0001209191-22-012392:0
19,639 股Common StockSEC:0001209191-22-002989:0
25,000 股@ US$13.865.4% 占其流量Common StockSEC:0001209191-21-071176:0
20 条申报中的 20 条
About Halstead Michael
Halstead Michael is Vice-Président Exécutif and President at Intra-Cellular Therapies, Inc. Across 19 filings in total, the 19 sampled recent filings cover the period from 2021-12-23 to 2025-04-02, with 0 in purchases and EUR 3361760 in sales, and the most common transaction nature is Levée d'options.
